查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1791479

芹菜素的全球市场

Apigenin
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 185 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年，全球芹菜素市场规模将达到 359,500 美元

全球芹菜素市场规模预计在2024年为313,600美元，预计到2030年将达到359,500美元，在2024-2030年的分析期内，复合年增长率为2.3%。本报告分析的细分市场之一，纯度等级为0.95的市场，预计复合年增长率为2.6%，到分析期结束时，市场规模将达到209,400美元。纯度等级为0.98的市场，预计在分析期间内，复合年增长率为1.6%。

美国市场规模估计为 85,400 美元，中国市场预计复合年增长率为 4.5%

预计到2024年，美国芹菜素市场规模将达到85,400美元。作为世界第二大经济体，中国市场规模预计到2030年将达到68,700美元，在2024-2030年的分析期间内，复合年增长率为4.5%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间内，这两个市场的复合年增长率分别为0.8%和1.7%。在欧洲，预计德国市场的复合年增长率为1.2%。

全球芹菜素市场－主要趋势与驱动因素摘要

芹菜素为何受到各行业关注？

芹菜素是一种天然存在的类黄酮，存在于多种植物中，包括洋甘菊、欧芹、芹菜和柑橘类水果，因其在製药、营养保健品、化妆品和机能性食品行业的应用而受到广泛关注。随着消费者偏好转向植物来源生物活性化合物，芹菜素因其潜在的健康促进特性和越来越多的科学检验而成为备受追捧的成分。在製药领域，对植物萃取物的需求激增，人们正在探索芹菜素在肿瘤学、心血管健康和神经保护方面的潜力。同时，在机能性食品和营养保健品行业，芹菜素已被用作旨在促进健康和长寿的膳食补充剂的关键成分。此外，清洁美容运动进一步促进了其在护肤和个人护理配方中的应用，将其添加到抗衰老面霜、精华液和防紫外线配方中。消费者对天然和植物来源成分的认识不断提高，增强了芹菜素的存在感，使其成为整体健康和保健解决方案的关键成分。

科技创新如何增强芹菜素的萃取和配方？

萃取和製剂技术的进步在提升芹菜素在工业应用中的商业性可行性方面发挥关键作用。传统的溶剂萃取方法如今已得到更高效方法的补充，例如超临界流体萃取、超音波辅助萃取 (UAE) 和酶水解，从而提高了产量、纯度和生物有效性。此外，奈米技术和封装技术（例如脂质体和聚合物奈米颗粒递送系统）的进展显着提高了芹菜素在药物和化妆品配方中的稳定性和吸收率。这些技术进步使得基于芹菜素的产品的开发成为可能，这些产品的生物功效得到改善，释放得到控制，使其能够应用于各个领域。此外，人工智慧驱动的製剂技术使製造商能够优化基于芹菜素的化合物，以用于靶向治疗应用，从而降低製造成本并提高扩充性。生物技术（尤其是微生物生物合成）的整合正在为永续和稳定的芹菜素生产铺平道路，减少对季节性植物来源的依赖，并提高供应链的弹性。随着技术进步提高了萃取效率和配方稳定性，芹菜素有望成为健康和保健产业的主流生物活性化合物。

哪些市场趋势推动了对芹菜素类产品的需求？

一些关键的市场趋势正在塑造对芹菜素类产品的需求，尤其是在膳食补充剂、药品和个人护理行业。消费者对天然和有机成分的偏好导致对植物来源生物活性成分的需求激增，使芹菜素成为膳食补充剂和机能性食品中合成化合物的首选替代品。精神活性和认知增强补充剂的日益普及进一步激发了人们对芹菜素的兴趣，研究证实了其在认知健康和神经保护方面的作用。同时，护肤产业正转向植物来源成分，推动芹菜素被纳入抗衰老、抗氧化和抗发炎护肤配方中。个人化营养和精准医疗的兴起也促进了芹菜素市场的扩张，因为科学研究正在揭示芹菜素在目标健康应用中的作用。此外，有利于在机能性食品和药品中使用天然类黄酮的监管变化也促进了芹菜素类产品的市场进入。电子商务和直销 (DTC) 健康品牌的蓬勃发展进一步加速了芹菜素的普及，使其更容易被全球注重健康的消费者所接受。这些趋势表明，芹菜素在多个消费主导产业中拥有持续成长的巨大潜力。

芹菜素市场扩张的主要成长动力是什么？

芹菜素市场的成长受到多种因素的推动，包括萃取和製剂技术的进步、消费者对植物来源补充剂需求的不断增长，以及其在药品、营养保健品和化妆品领域的应用范围不断扩大。越来越多的临床研究投入支持芹菜素的治疗潜力，促使药厂探索包含这种生物活性类黄酮的新药物配方。机能性食品和饮料产业的扩张，特别是在北美、欧洲和亚太等地区，促进了对富含芹菜素的产品的需求不断增长，这些产品旨在增强免疫力、提升认知功能和促进代谢健康。此外，清洁美容运动和永续性主导的护肤创新，进一步加速了芹菜素在化妆品配方中的应用。越来越多的监管机构核准使用类黄酮功能性成分，这推动了全球市场的成长，促使企业更加重视合规性、安全性和功效，以满足不断变化的消费者期望。数位健康平台和个人化健康解决方案的快速发展也塑造着市场趋势，为消费者提供了根据其特定健康需求量身定制的芹菜素产品。由于持续的技术创新、不断扩展的行业应用以及不断变化的消费者偏好，芹菜素市场正在不断扩大，为多个行业的製造商和相关人员提供了新的机会。

部分

类型（0.95 纯度等级、0.98 纯度等级、其他类型）、用途（医药/保健用途、食品添加物用途、化妆品/护肤用途、其他用途）

受访公司范例

  • Anhui Sinotech Industrial
  • Cayman Chemical Company
  • Chengdu Chenlv Biological Technology
  • Codeage LLC
  • Enzo Life Sciences, Inc.
  • Fuyang Bestop Import And Export Ltd.
  • Glentham Life Sciences Ltd.
  • HealthTech BioActives
  • Hello Bio Ltd.
  • INDOFINE Chemical Company, Inc.
  • Jinan Tantu Chemicals
  • Lanyor Biotech Co., Ltd.
  • Mianyang Di'ao Pharmaceutical Co., Ltd.
  • S. Nihar Exports
  • Selleck Chemicals
  • Shaanxi Pioneer Biotech Co., Ltd.
  • Sunriver Biotech
  • Wuhan Hengheda Pharm Co., Ltd.
  • Xi'an Arisun ChemPharm Co., Ltd.
  • Xi'an Bettering Biotech Co., Ltd.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global Industry Analysts 没有遵循典型的 LLM 或特定于行业的 SLM查询，而是建立了一个从世界各地的专家收集的内容库，其中包括视频录像、博客、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP29200

Global Apigenin Market to Reach US$359.5 Thousand by 2030

The global market for Apigenin estimated at US$313.6 Thousand in the year 2024, is expected to reach US$359.5 Thousand by 2030, growing at a CAGR of 2.3% over the analysis period 2024-2030. 0.95 Purity Level, one of the segments analyzed in the report, is expected to record a 2.6% CAGR and reach US$209.4 Thousand by the end of the analysis period. Growth in the 0.98 Purity Level segment is estimated at 1.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$85.4 Thousand While China is Forecast to Grow at 4.5% CAGR

The Apigenin market in the U.S. is estimated at US$85.4 Thousand in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$68.7 Thousand by the year 2030 trailing a CAGR of 4.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.8% and 1.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Apigenin Market - Key Trends & Drivers Summarized

Why Is Apigenin Gaining Prominence Across Diverse Industries?

Apigenin, a naturally occurring flavonoid found in various plant sources such as chamomile, parsley, celery, and citrus fruits, is gaining widespread attention for its applications across pharmaceuticals, nutraceuticals, cosmetics, and functional food industries. As consumer preferences shift toward plant-derived bioactive compounds, apigenin is emerging as a highly sought-after ingredient due to its potential health-promoting properties and increasing scientific validation. The demand for botanical extracts in the pharmaceutical sector has surged, with apigenin being explored for its potential in oncology, cardiovascular health, and neuroprotection. Meanwhile, the functional food and nutraceutical industry has embraced apigenin as a key ingredient in dietary supplements aimed at promoting overall wellness and longevity. Additionally, the clean beauty movement has further propelled its use in skincare and personal care formulations, where it is being integrated into anti-aging creams, serums, and UV-protection formulations. The expanding consumer awareness regarding natural and plant-based ingredients is reinforcing the prominence of apigenin, positioning it as a crucial component in holistic health and wellness solutions.

How Are Technological Innovations Enhancing Apigenin Extraction and Formulation?

The advancement of extraction technologies and formulation techniques has played a pivotal role in improving the commercial viability of apigenin for industrial applications. Traditional solvent extraction methods are now being supplemented with more efficient approaches such as supercritical fluid extraction, ultrasound-assisted extraction (UAE), and enzymatic hydrolysis, which enhance yield, purity, and bioavailability. Furthermore, advancements in nanotechnology and encapsulation techniques, such as liposomal and polymeric nanoparticle delivery systems, have significantly improved the stability and absorption of apigenin in both pharmaceutical and cosmetic formulations. These innovations have made it possible to develop apigenin-based products with enhanced bioefficacy and controlled-release mechanisms, increasing its applicability across multiple sectors. Additionally, AI-driven formulation techniques are enabling manufacturers to optimize apigenin-based compounds for targeted therapeutic applications, reducing production costs and improving scalability. The integration of biotechnology, particularly microbial biosynthesis, is also paving the way for sustainable and consistent production of apigenin, reducing dependence on seasonal plant sources and improving supply chain resilience. As technological advancements continue to enhance extraction efficiency and formulation stability, apigenin is set to become a mainstream bioactive compound in the health and wellness industry.

What Market Trends Are Driving the Demand for Apigenin-Based Products?

Several key market trends are shaping the demand for apigenin-based products, particularly in the nutraceutical, pharmaceutical, and personal care industries. The increasing consumer inclination toward natural and organic ingredients has led to a surge in demand for plant-derived bioactives, positioning apigenin as a preferred alternative to synthetic compounds in dietary supplements and functional foods. The growing popularity of nootropics and cognitive-enhancing supplements has further fueled interest in apigenin, with research supporting its role in cognitive health and neuroprotection. Meanwhile, the skincare industry is witnessing a shift towards botanically sourced ingredients, driving the incorporation of apigenin into anti-aging, antioxidant-rich, and anti-inflammatory skincare formulations. The rise of personalized nutrition and precision medicine has also contributed to the expansion of the apigenin market, as scientific research continues to uncover its role in targeted health applications. Additionally, regulatory shifts promoting the use of naturally occurring flavonoids in functional foods and pharmaceuticals have facilitated market entry for apigenin-based products. The increasing penetration of e-commerce and direct-to-consumer (DTC) wellness brands has further accelerated the adoption of apigenin, making it more accessible to health-conscious consumers worldwide. These evolving trends indicate a sustained market trajectory, with apigenin poised for significant growth across multiple consumer-driven industries.

What Are the Key Growth Drivers Fueling the Apigenin Market Expansion?

The growth in the apigenin market is driven by several factors, including advancements in extraction and formulation technologies, increasing consumer demand for botanical-based supplements, and the expanding application scope in pharmaceuticals, nutraceuticals, and cosmetics. The rising investment in clinical research supporting apigenin’s therapeutic potential is encouraging pharmaceutical companies to explore new drug formulations incorporating this bioactive flavonoid. The functional food and beverage industry’s expansion, particularly in regions such as North America, Europe, and Asia-Pacific, is contributing to higher demand for apigenin-enriched products targeting immune support, cognitive function, and metabolic health. Additionally, the clean beauty movement and sustainability-driven innovations in skincare are further accelerating apigenin’s adoption in cosmetic formulations. The increasing regulatory approvals for flavonoid-based functional ingredients are facilitating global market growth, prompting companies to focus on compliance, safety, and efficacy to meet evolving consumer expectations. The rapid growth of digital health platforms and personalized wellness solutions is also shaping market trends, allowing consumers to access apigenin-based products tailored to their specific health needs. With ongoing innovations, expanding industry applications, and evolving consumer preferences, the apigenin market is set for continuous expansion, offering new opportunities for manufacturers and stakeholders across multiple sectors.

SCOPE OF STUDY:

The report analyzes the Apigenin market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (0.95 Purity Level, 0.98 Purity Level, Other Types): Application (Pharma & Healthcare Application, Food Additives Application, Cosmetic & Skin Care Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 44 Featured) -

  • Anhui Sinotech Industrial
  • Cayman Chemical Company
  • Chengdu Chenlv Biological Technology
  • Codeage LLC
  • Enzo Life Sciences, Inc.
  • Fuyang Bestop Import And Export Ltd.
  • Glentham Life Sciences Ltd.
  • HealthTech BioActives
  • Hello Bio Ltd.
  • INDOFINE Chemical Company, Inc.
  • Jinan Tantu Chemicals
  • Lanyor Biotech Co., Ltd.
  • Mianyang Di'ao Pharmaceutical Co., Ltd.
  • S. Nihar Exports
  • Selleck Chemicals
  • Shaanxi Pioneer Biotech Co., Ltd.
  • Sunriver Biotech
  • Wuhan Hengheda Pharm Co., Ltd.
  • Xi'an Arisun ChemPharm Co., Ltd.
  • Xi'an Bettering Biotech Co., Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Apigenin - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Interest in Flavonoid-Based Natural Compounds Spurs Demand for Apigenin in Dietary Supplements
    • Growing Scientific Validation of Anti-Inflammatory and Antioxidant Benefits Strengthens Business Case for Apigenin
    • Expansion of Nutraceutical and Functional Food Sectors Accelerates Inclusion of Apigenin as a Bioactive Ingredient
    • Increased Consumer Focus on Natural Health Products Throws the Spotlight on Botanical Extracts Like Apigenin
    • Advancements in Extraction and Purification Technologies Drive Cost-Efficient and High-Purity Production
    • Rising Interest in Plant-Based Ingredients in Cosmetics and Personal Care Fuels Use of Apigenin in Skincare Formulations
    • Surge in Cancer Research and Preclinical Studies Expands Therapeutic Interest in Apigenins Cytoprotective Properties
    • Growth in Herbal Drug Development and TCM Integration Generates New Use-Cases for Apigenin
    • Regulatory Support for Natural Antioxidants in Food Preservation Drives Adoption in Clean Label Foods
    • Demand for Neuroprotective and Cognitive Health Supplements Accelerates Application of Apigenin in Brain Health
    • Expansion of Vegan and Plant-Based Nutrition Trends Creates Favorable Market Conditions
    • Increasing Inclusion of Apigenin in Sports and Performance Nutrition Formulations Sustains Growth
    • Collaboration Between Supplement Manufacturers and Botanical Research Institutions Enhances Product Innovation
    • Availability of Apigenin in Multiple Delivery Formats Broadens Consumer Appeal
    • Growing Demand for Immune-Boosting and Anti-Aging Products Strengthens Market for Bioflavonoid Compounds
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Apigenin Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Apigenin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Apigenin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for 0.95 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for 0.95 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for 0.95 Purity Level by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for 0.98 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for 0.98 Purity Level by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for 0.98 Purity Level by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 14: USA Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 15: USA Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: USA 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 17: Canada Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 18: Canada Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: Canada 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • JAPAN
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 20: Japan Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: Japan Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: Japan 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • CHINA
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 23: China Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: China Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: China 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • EUROPE
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 26: Europe Recent Past, Current & Future Analysis for Apigenin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 27: Europe Historic Review for Apigenin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Europe 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 29: Europe Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Europe Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Europe 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • FRANCE
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 32: France Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: France Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: France 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • GERMANY
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 35: Germany Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Germany Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Germany 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 38: Italy Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Italy Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Italy 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 41: UK Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: UK Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: UK 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 44: Spain Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Spain Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Spain 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 47: Russia Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Russia Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Russia 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 50: Rest of Europe Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Rest of Europe Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Rest of Europe 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 53: Asia-Pacific Recent Past, Current & Future Analysis for Apigenin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 54: Asia-Pacific Historic Review for Apigenin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Asia-Pacific 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 56: Asia-Pacific Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Asia-Pacific Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: Asia-Pacific 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 59: Australia Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Australia Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Australia 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • INDIA
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 62: India Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: India Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: India 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 65: South Korea Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: South Korea Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: South Korea 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 68: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Rest of Asia-Pacific Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Rest of Asia-Pacific 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 71: Latin America Recent Past, Current & Future Analysis for Apigenin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 72: Latin America Historic Review for Apigenin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Latin America 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 74: Latin America Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Latin America Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: Latin America 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 77: Argentina Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Argentina Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Argentina 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 80: Brazil Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Brazil Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Brazil 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 83: Mexico Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Mexico Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Mexico 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 86: Rest of Latin America Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Rest of Latin America Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Rest of Latin America 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 89: Middle East Recent Past, Current & Future Analysis for Apigenin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 90: Middle East Historic Review for Apigenin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Middle East 15-Year Perspective for Apigenin by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 92: Middle East Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Middle East Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Middle East 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 95: Iran Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Iran Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Iran 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 98: Israel Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Israel Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Israel 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 101: Saudi Arabia Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Saudi Arabia Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Saudi Arabia 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 104: UAE Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UAE Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: UAE 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 107: Rest of Middle East Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Rest of Middle East Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Rest of Middle East 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030
  • AFRICA
    • Apigenin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 110: Africa Recent Past, Current & Future Analysis for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Africa Historic Review for Apigenin by Type - 0.95 Purity Level, 0.98 Purity Level and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: Africa 15-Year Perspective for Apigenin by Type - Percentage Breakdown of Value Sales for 0.95 Purity Level, 0.98 Purity Level and Other Types for the Years 2015, 2025 & 2030

IV. COMPETITION